1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60C2232E96019237100258975004B55A9
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/0C2232E96019237100258975004B55A9?OpenDocument
18
19OpenDocument
2018.97.9.172
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Patient Focused Services » Patient-Centric Initiatives

Document Excerpt: Patient-Driven Growth: Maximizing Patient Journey Mapping Capabilities

DB Image

ID: MD-853


Features:

16 Info Graphics

23 Data Graphics

360+ Metrics

31 Narratives


Pages/Slides: 4


Published: 2023


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5753 “Patient-Driven Growth: Maximizing Patient Journey Mapping Capabilities”.

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Clinical Research; Laboratories


Companies Profiled:
Alkermes; Astellas; AstraZeneca; Bayer; BELLUS Health; Biogen; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; CSL Behring; Debiopharm; Eli Lilly and Company; GlaxoSmithKline ; Janssen; Jazz Pharmaceuticals; Kala Pharmaceuticals; Inc.; Mitsubishi Tanabe Pharma Corporation; Novartis; Novo Nordisk; Organon; OTSUKA; Pfizer; Sanofi; Sunovion; Takeda Pharmaceuticals; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.